The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of cerebral aneurysms, expansion of neurointerventional procedures, increasing availability of skilled neurovascular specialists, growing hospital investments in advanced neurocare, wider adoption of minimally invasive stroke treatments.
The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising investments in neurovascular R&D, expansion of aging population with vascular disorders, growing adoption of next-generation embolization devices, increasing focus on improving procedural outcomes. Major trends in the forecast period include increasing adoption of flow diversion stents, rising use of liquid embolic systems, growing preference for minimally invasive neurointerventions, expansion of coil technologies with advanced coatings, enhanced focus on precision neurovascular devices.
The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King’s College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.
Leading companies in the neurovascular embolization devices market are focusing on developing advanced solutions, such as next-generation flow diverters, to replace traditional aneurysm treatment methods. A next-generation flow diverter is a device designed to enhance procedural safety and effectiveness by improving vessel wall apposition, reducing clotting risk, and enabling easier deployment in complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter as part of its neurovascular portfolio. This innovation replaces older aneurysm treatment devices by offering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It features improved thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. When integrated with Stryker’s training and physician support programs, it provides a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, streamlines procedural workflows, and supports wider adoption of flow diversion therapy in neurovascular care.
In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc.
North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurovascular embolization devices market by increasing costs of imported platinum coils, nitinol stents, microcatheters, polymers, and precision-manufactured components used in embolization systems. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on specialized imported materials, while Asia-Pacific faces higher costs for device exports and component sourcing. These tariffs are raising device prices and impacting procurement budgets for neurointerventional procedures. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of high-value neurovascular devices.
The neurovascular embolization devices market research report is one of a series of new reports that provides neurovascular embolization devices market statistics, including neurovascular embolization devices industry global market size, regional shares, competitors with a neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. This neurovascular embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.
The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.
The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising investments in neurovascular R&D, expansion of aging population with vascular disorders, growing adoption of next-generation embolization devices, increasing focus on improving procedural outcomes. Major trends in the forecast period include increasing adoption of flow diversion stents, rising use of liquid embolic systems, growing preference for minimally invasive neurointerventions, expansion of coil technologies with advanced coatings, enhanced focus on precision neurovascular devices.
The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King’s College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.
Leading companies in the neurovascular embolization devices market are focusing on developing advanced solutions, such as next-generation flow diverters, to replace traditional aneurysm treatment methods. A next-generation flow diverter is a device designed to enhance procedural safety and effectiveness by improving vessel wall apposition, reducing clotting risk, and enabling easier deployment in complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter as part of its neurovascular portfolio. This innovation replaces older aneurysm treatment devices by offering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It features improved thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. When integrated with Stryker’s training and physician support programs, it provides a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, streamlines procedural workflows, and supports wider adoption of flow diversion therapy in neurovascular care.
In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc.
North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurovascular embolization devices market by increasing costs of imported platinum coils, nitinol stents, microcatheters, polymers, and precision-manufactured components used in embolization systems. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on specialized imported materials, while Asia-Pacific faces higher costs for device exports and component sourcing. These tariffs are raising device prices and impacting procurement budgets for neurointerventional procedures. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of high-value neurovascular devices.
The neurovascular embolization devices market research report is one of a series of new reports that provides neurovascular embolization devices market statistics, including neurovascular embolization devices industry global market size, regional shares, competitors with a neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. This neurovascular embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.
The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.
The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurovascular Embolization Devices Market Characteristics
3. Neurovascular Embolization Devices Market Supply Chain Analysis
4. Global Neurovascular Embolization Devices Market Trends and Strategies
5. Neurovascular Embolization Devices Market Analysis of End Use Industries
7. Global Neurovascular Embolization Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurovascular Embolization Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurovascular Embolization Devices Market Segmentation
10. Neurovascular Embolization Devices Market Regional and Country Analysis
11. Asia-Pacific Neurovascular Embolization Devices Market
12. China Neurovascular Embolization Devices Market
13. India Neurovascular Embolization Devices Market
14. Japan Neurovascular Embolization Devices Market
15. Australia Neurovascular Embolization Devices Market
16. Indonesia Neurovascular Embolization Devices Market
17. South Korea Neurovascular Embolization Devices Market
18. Taiwan Neurovascular Embolization Devices Market
19. South East Asia Neurovascular Embolization Devices Market
20. Western Europe Neurovascular Embolization Devices Market
21. UK Neurovascular Embolization Devices Market
22. Germany Neurovascular Embolization Devices Market
23. France Neurovascular Embolization Devices Market
24. Italy Neurovascular Embolization Devices Market
25. Spain Neurovascular Embolization Devices Market
26. Eastern Europe Neurovascular Embolization Devices Market
27. Russia Neurovascular Embolization Devices Market
28. North America Neurovascular Embolization Devices Market
29. USA Neurovascular Embolization Devices Market
30. Canada Neurovascular Embolization Devices Market
31. South America Neurovascular Embolization Devices Market
32. Brazil Neurovascular Embolization Devices Market
33. Middle East Neurovascular Embolization Devices Market
34. Africa Neurovascular Embolization Devices Market
36. Neurovascular Embolization Devices Market Competitive Landscape and Company Profiles
37. Neurovascular Embolization Devices Market Other Major and Innovative Companies
40. Neurovascular Embolization Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurovascular Embolization Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurovascular embolization devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular embolization devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products2) By Treatment: Neurovascular Hemorrhage Management; Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils; Bare Platinum Coils; Coils With Hydrogel Coatings2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics; Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology; Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips; Stainless Steel Clips
5) By Other Products: Balloons For Embolization; Microcatheters
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Kaneka Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical LLC; Integer Holdings Corporation; Merit Medical Systems Inc; Penumbra Inc; Asahi Intecc Co Ltd; MicroVention Inc; Balt USA LLC; Imperative Care Inc; Acandis GmbH & Co KG; Rapid Medical Ltd; Vesalio LLC; Phenox GmbH; Cerenovus; Sequent Medical Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurovascular Embolization Devices market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Kaneka Corporation
- Terumo Corporation
- B Braun Melsungen AG
- Cook Medical LLC
- Integer Holdings Corporation
- Merit Medical Systems Inc
- Penumbra Inc
- Asahi Intecc Co Ltd
- MicroVention Inc
- Balt USA LLC
- Imperative Care Inc
- Acandis GmbH & Co KG
- Rapid Medical Ltd
- Vesalio LLC
- Phenox GmbH
- Cerenovus
- Sequent Medical Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.47 Billion |
| Forecasted Market Value ( USD | $ 1.91 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
